Home » People & Blogs » Intervaccs development during 2013-14

Intervaccs development during 2013-14

Written By Intervacc on Wednesday, Jul 09, 2014 | 10:56 AM

 
Presentation about Intervaccs ongoing work 2013-14, in Swedish, by CEO Jan-Ingmar Flock. Especially focused on the development of a safe and efficacious vaccine Strangvac® against the highly contagious disease strangles in horses caused by Streptococcus equi.